The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sjögren's syndrome

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

(2009) R. Seror et al.   ANNALS OF THE RHEUMATIC DISEASES

FLT3 inhibition and mechanisms of drug resistance in mutant FLT3-positive AML

(2009) Ellen Weisberg et al.   DRUG RESISTANCE UPDATES

Sjögren’s Syndrome

(2009) Kristine P Ng et al.   DRUGS & AGING

Hematologic Manifestations and Predictors of Lymphoma Development in Primary Sjögren Syndrome

(2009) Evangelia Baimpa et al.   MEDICINE

Is the blood B-cell subset profile diagnostic for Sjogren syndrome?

(2008) A Binard et al.   ANNALS OF THE RHEUMATIC DISEASES

FLT3 ligand and not TSLP is the key regulator of IL-7-independent B-1 and B-2 B lymphopoiesis

(2008) C. T. Jensen et al.   BLOOD

Intra-Articular Fms-Like Tyrosine Kinase 3 Ligand Expression Is a Driving Force in Induction and Progression of Arthritis

(2008) Mats Dehlin et al.   PLoS One